Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by muscle weakness and fatigue. As with any medical condition, companies involved in the field of Myasthenia Gravis play a crucial role in advancing research, developing treatments, and supporting individuals affected by the disease. One notable company in this space is Alexion Pharmaceuticals, which has been...